Organogenesis Inc.

Organogenesis Inc.

Organogenesis has the skinny on replacement tissue. Flagship product Apligraf is a human skin substitute approved to treat diabetic foot ulcers and venous leg ulcers caused by poor circulation. Rejection-resistant Apligraf is bio-engineered using living skin cells and has been used to treat chronic open wounds in some 250,000 patients; the company is developing a next-generation version of the material (using its VCT technology) using all human components. In addition to Apligraf, Organogenesis offers a line of biomaterials used in a range of surgical procedures to seal or reconstruct soft tissue, and it also develops regenerative technologies in the area of cosmetic skin rejuvenation.

Contact Details

Office Address

Organogenesis Inc.
150 Dan Road
Canton, Massachusetts, USA 02021
Phone: (781) 575-0775
Fax: (781) 575-0440

Executives

President and CEO

Geoff MacKay

EVP, COO, and CFO

Gary S. Gillheeney Sr.

Business Reviews for Organogenesis Inc.

Related Companies